Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,942Revenue (TTM) $M4,463Net Margin (%)13.4Altman Z-Score2.3
Enterprise Value $M16,576EPS (TTM) $0.9Operating Margin %23.5Piotroski F-Score6
P/E(ttm)21.6Beneish M-Score-2.6Pre-tax Margin (%)17.3Higher ROA y-yN
Price/Book3.310-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %29.7Current Ratio3.2Lower Leverage y-yY
Price/Free Cash Flow28.2y-y EBITDA Growth Rate %2.5ROA % (ttm)5.7Higher Current Ratio y-yY
Dividend Yield %2.4PEG0.8ROE % (ttm)16.0Less Shares Outstanding y-yY
Payout Ratio %41.0Shares Outstanding M683ROIC % (ttm)11.9Gross Margin Increase y-yN

Gurus Latest Trades with GRFS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GRFSJohn Paulson 2016-09-30 Reduce-0.85%$15.81 - $17.25
($16.46)
$ 14.56-12%Reduce -66.26%2,478,600
GRFSMario Gabelli 2016-09-30 Reduce$15.81 - $17.25
($16.46)
$ 14.56-12%Reduce -27.20%40,625
GRFSJohn Paulson 2016-06-30 Reduce-1.2%$14.54 - $17.3
($15.72)
$ 14.56-7%Reduce -58.11%7,345,166
GRFSMario Gabelli 2016-06-30 Reduce$14.54 - $17.3
($15.72)
$ 14.56-7%Reduce -2.79%55,800
GRFSJohn Paulson 2016-03-31 Reduce-0.72%$14.2 - $16.2
($15.14)
$ 14.56-4%Reduce -29.29%17,533,764
GRFSRon Baron 2016-03-31 Add$14.2 - $16.2
($15.14)
$ 14.56-4%Add 7.14%75,000
GRFSJohn Paulson 2015-12-31 Add0.7%$15.84 - $17.79
($16.91)
$ 14.56-14%Add 39.86%24,796,280
GRFSRon Baron 2015-12-31 Add0.01%$15.84 - $17.79
($16.91)
$ 14.56-14%Add 100.00%70,000
GRFSMario Gabelli 2015-12-31 Add0.01%$15.84 - $17.79
($16.91)
$ 14.56-14%Add 119.08%57,400
GRFSJohn Paulson 2015-09-30 Reduce-0.01%$14.75 - $16.78
($15.87)
$ 14.56-8%Reduce -0.52%35,458,280
GRFSRon Baron 2015-09-30 Add$14.75 - $16.78
($15.87)
$ 14.56-8%Add 6.06%70,000
GRFSMario Gabelli 2015-09-30 Reduce$14.75 - $16.78
($15.87)
$ 14.56-8%Reduce -13.25%52,400
GRFSJohn Paulson 2015-06-30 Add$15.2 - $17.43
($16.22)
$ 14.56-10%Add 0.11%35,642,080
GRFSRon Baron 2015-06-30 Reduce$15.2 - $17.43
($16.22)
$ 14.56-10%Reduce -12.70%66,000
GRFSMario Gabelli 2015-06-30 Add$15.2 - $17.43
($16.22)
$ 14.56-10%Add 8.37%60,400
GRFSJohn Paulson 2015-03-31 Add$15.69 - $17.78
($16.74)
$ 14.56-13%Add 0.05%35,603,480
GRFSMario Gabelli 2015-03-31 Add$15.69 - $17.78
($16.74)
$ 14.56-13%Add 16.27%55,736
GRFSJohn Paulson 2014-12-31 Reduce-0.27%$14.89 - $18.62
($17.21)
$ 14.56-15%Reduce -9.25%35,584,280
GRFSMario Gabelli 2014-12-31 Reduce$14.89 - $18.62
($17.21)
$ 14.56-15%Reduce -4.80%47,936
GRFSRon Baron 2014-12-31 Reduce$14.89 - $18.62
($17.21)
$ 14.56-15%Reduce -11.68%75,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GRFS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GRFS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about GRFS:

    News about GRFS:

    Articles On GuruFocus.com
    John Paulson's Largest 3rd Quarter Trades Dec 01 2016 
    John Paulson Raises Stake in Valeant, Teva Pharmaceutical Mar 18 2016 
    Gold-Focused Guru John Paulson Reports First Quarter Holdings May 22 2014 
    Is Grifols Being Overlooked? Mar 19 2014 
    John Paulson's Top Five Holdings Nov 20 2013 
    John Paulson's Top Five Holdings Sep 12 2013 
    Baron Funds Comments on Grifols SA Aug 30 2012 
    Friday Value Overview Aug 19 2011 

    More From Other Websites
    Ligand Pharmaceuticals Inc. (LGND): Hedge Fund Sentiment Unchanged Dec 05 2016
    ETFs with exposure to Grifols SA : December 2, 2016 Dec 02 2016
    John Paulson's Largest 3rd Quarter Trades Dec 01 2016
    What Explains the Huge Jump in Louisiana-Pacific Corporation (LPX)’s Hedge Fund Ownership? Nov 25 2016
    Grifols SA :GRFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 Nov 11 2016
    Sales of the Bioscience Division grow by +6.5%, increasing Grifols’ revenues to EUR 2,952 million... Nov 08 2016
    Sales of the Bioscience Division grow by +6.5%, increasing Grifols' revenues to EUR 2,952 million Nov 08 2016
    The CLIA Lab at the Grifols Immunohematology Center Will Now Offer Both Serology and Molecular Tests Oct 20 2016
    The CLIA Lab at the Grifols Immunohematology Center Will Now Offer Both Serology and Molecular Tests Oct 20 2016
    Grifols relocates its headquarters in Germany to a new office building Oct 13 2016
    Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : October... Oct 07 2016
    5 Big Dividend Stocks Billionaire John Paulson Loves Sep 08 2016
    Grifols Opens Diagnostic Training Center in Dubai Sep 05 2016
    Grifols Opens Diagnostic Training Center in Dubai Sep 05 2016
    New Zika Screening Rule Could Boost Hologic Sales Growth Aug 26 2016
    ETF’s with exposure to Grifols SA : August 25, 2016 Aug 25 2016
    Grif_ls support the Canadian Blood Services' Missing Type Campaign Aug 16 2016
    The results of phase I clinical trial of the Araclon Biotech Alzheimer's vaccine support its... Aug 01 2016
    Sales of the Bioscience Division grow by +7.0%, increasing Grifols' revenues by +2.7% to EUR 1,952... Jul 28 2016
    Sales of the Bioscience Division grow by +7.0%, increasing Grifols’ revenues by +2.7% to EUR 1,952... Jul 28 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)